Research Tracker›Biomarker Atlas›Type 1 Diabetes›GAD65 autoantibodies

GAD65 autoantibodies in Type 1 Diabetes

In Type 1 Diabetes, published studies report higher levels of GAD65 autoantibodies than in the reference group of the cited comparison (T1D patients vs healthy (antibody-negative) individuals). The source does not tie this marker to a specific symptom cluster, so it is best read as a biological signal rather than a symptom predictor. The evidence summarised here comes from Luo et al. 2004 and reflects averages across cohorts rather than any single patient's result.

↑ ElevatedMetabolic

Summary

Direction in Type 1 Diabetes↑ Elevated — higher than in the comparison group
CategoryMetabolic
Compared againstT1D patients vs healthy (antibody-negative) individuals
SourceLuo et al. 2004 — doi:10.1007/s00125-004-1495-3
Condition atlasType 1 Diabetes Biomarker Atlas

Related Metabolic markers in Type 1 Diabetes

Full list: Type 1 Diabetes Biomarker Atlas.

Frequently asked questions

Is GAD65 autoantibodies high or low in Type 1 Diabetes?

Elevated. Studies summarised in the OSMF atlas report higher GAD65 autoantibodies in Type 1 Diabetes than in the reference group of the cited comparison (T1D patients vs healthy (antibody-negative) individuals). Source: Luo et al. 2004.

Which test measures GAD65 autoantibodies?

The atlas record does not list a standardised clinical test code (LOINC) for GAD65 autoantibodies, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

Is one abnormal GAD65 autoantibodies result diagnostic of Type 1 Diabetes?

No. No single biomarker is diagnostic of Type 1 Diabetes. GAD65 autoantibodies findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). GAD65 autoantibodies in Type 1 Diabetes: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/type-1-diabetes/gad65-autoantibodies.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-07-03 · Page generated from type-1-diabetes.json · Browse: Type 1 Diabetes atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.